Brian Markison
2018
In 2018, Brian Markison earned a total compensation of $1.1M as President and Chief Executive Officer at RVL Pharmaceuticals plc, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $475,599 |
|---|---|
| Salary | $633,262 |
| Total | $1,108,861 |
Markison received $633.3K in salary, accounting for 57% of the total pay in 2018.
Markison also received $475.6K in non-equity incentive plan.
Rankings
In 2018, Brian Markison's compensation ranked 8,692nd out of 14,244 executives tracked by ExecPay. In other words, Markison earned more than 39.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,692 out of 14,244 | 39th |
Division Manufacturing | 3,467 out of 5,765 | 40th |
Major group Chemicals And Allied Products | 1,310 out of 2,128 | 38th |
Industry group Drugs | 1,095 out of 1,817 | 40th |
Industry Pharmaceutical Preparations | 853 out of 1,391 | 39th |
Source: SEC filing on April 26, 2019.
Markison's colleagues
We found three more compensation records of executives who worked with Brian Markison at RVL Pharmaceuticals plc in 2018.
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020
RVL Pharmaceuticals plc CEO Brian Markison's 2018 pay slips 10% to $1.1M
April 26, 2019